Parkinson’s Disease
167 results.
When it comes to biomedical research and science education, a year can make all the difference. In 2016, we celebrated Van Andel…
For the estimated between 7 million and 10 million people living with Parkinson’s disease, there’s new reason for hope: Van Andel Research…
GRAND RAPIDS, Mich. (Dec. 7, 2016)—A new investigational drug originally developed for type 2 diabetes is being readied for human clinical trials in search of…
A few years ago, Caryl Sortwell, a Michigan State University College of Human Medicine Parkinson's researcher, was asked by Jeff MacKeigan, a…
HIGHLIGHTS A clinical trial is now underway at Cedars-Sinai in Los Angeles to test the efficacy and safety of a type II diabetes drug as…
GRAND RAPIDS, Mich. (Aug. 8, 2016)—They’re two of the biggest mysteries in Parkinson’s disease research—where does the disease start? And how can it be stopped…
GRAND RAPIDS, Mich. (July 27, 2016)—Clues that point toward new risk mechanisms for developing Parkinson’s disease are hiding in some unusual spots, according to
Note: To read the commentary published in the Journal of Parkinson's Disease click here.
Investigators will focus on safety for long-term use in non-cancer…